Clinical Trial Update: A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for TQB3117 tablets in patients with advanced malignant cancer. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• TQB3117

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Malignant Cancer | Phase 1 | Status: NOT_YET_RECRUITING